Management Team

Robert E. W. Hancock, OC OBC FRSC

CEO

Robert Hancock is a leading researcher at the University of British  Columbia, a Killam Professor of Microbiology and Immunology, and a Canada Research Chair in Health and Genomics. Receiving his PhD in  1975 he has become one of the worlds most highly cited researchers. He is  a co-founder of several companies, both private and public, including  Migenix, Inimex, ABT Innovations, and Sepset Biotherapeutics. He has won  major health research awards and is an Officer of the Order of Canada

Jan Burian, PhD

Founder / Chief Technical Offcier

Dr. Jan Burian is a successful biochemist and molecular biologist with  extensive knowledge in operations, scale-up of fermentative API-  production, research and development. He has numerous academic  publications to his name. He previously held a site directorship with Pfizer.  Dr. Burian is the alternate qualified person in charge under the Health  Canada license for the production of psilocybin.

Jen Gretchen, CPA, CA

CFO

Jen Gretchen obtained her CA designation in 2014 after articling with  KPMG. She has managerial experience in financial planning, analysis and  reporting. She has spent her career working with progressive tech  companies including Qualcomm and has assisted multiple companies  through IPO and M&A transactions.

Jay Van der Vlugt, BSC

Senior Biochemist

Jay Van der Vlugt is a trained biochemist with extensive experience  working with narcotics and controlled substances over the last 6 years and  is the qualified person in charge under the Health Canada license for the  production of psilocybin. He has held senior roles in regulatory,  compliance and intellectual property management

Board of Directors

Bob Hancock Headshot

Robert E. W. Hancock, OC OBC FRSC

CEO

Robert Hancock is a leading researcher at the University of British  Columbia, a Killam Professor of Microbiology and Immunology, and a Canada Research Chair in Health and Genomics. Receiving his PhD in  1975 he has become one of the worlds most highly cited researchers. He is  a co-founder of several companies, both private and public, including  Migenix, Inimex, ABT Innovations, and Sepset Biotherapeutics. He has won  major health research awards and is an Officer of the Order of Canada

Dan Polonenko, PhD

Director

Dan Polonenko is a principal and patent agent with Gowling WLG. His  practice involves patent drafting and prosecution in the field of life  sciences. Additionally, Dan provides business-focused strategic IP and  technology commercialization services. A registered patent agent in both  Canada and the United States. Dan has over 20 years of experience in the  Canadian biotech industry.

Omar Rasul Headshot

Omar Rasul MBA, CPA, CA, CMA, CFA

Proposed Director and Audit Committee Chair

Omar Rasul is the former CFO of AIG Insurance Company of Canada,  Divisional CFO for Citibank and a major Canadian Bank. Also held global  and regional functional head positions with AIG and Citibank in NY USA. A  finance and risk management executive with deep finance knowledge and  broad based cross functional experience gained at leading global  organization like AIG, Citigroup and major Canadian banks. Expertise in the  areas of corporate governance. business strategy, financial planning and  analysis, risk and capital management, investments, treasury, capital  markets and financial controllership.